Global Briefing 2018: Radiopharmaceutical Market Therapeutic Survey Analysis Report by Type, Applications and Major Key Findings

Radiopharmaceutical Market is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person’s specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.

Major Stackholders in the Radiopharmaceutical Market are Jubilant Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.

Avail Sample for this Report at:

Market Segmentation

The global radiopharmaceutical market is segmented by type, type of test, application, route of administration, and end user.

By type, it is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. Diagnostic type radiopharmaceutical is further sub-segmented into

SPECT radiopharmaceutical

  • Technetium-99m,
  • Thallium-201,
  • Iodine-123, and

PET radiopharmaceutical.

  • F-18,
  • Rubidium-82
  • and others.

Therapeutic type radiopharmaceutical is further sub-segmented into

  • beta emitters,
  • alpha emitters,

By type of test, it is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. Whereas, a bone scan is further sub-segmented into Technetium-99m 1st, fluoride-18 2nd, and others. Myocardial Perfusion Scan, Type is sub-segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan by type is segmented into Xenon-133, Krypton-81m, and others. And, White blood cell Scan is sub-segmented into Indium-111 and others.

Access Report @

By application, it is segmented into oncology, cardiology, neurology, urology, and others. Oncology segment is further segmented into following applications; prostate cancer, bone cancer, breast cancer and others. Cardiology segment is further segmented into following applications; coronary artery disease, cardiomyopathy and others. Neurology segment is further segmented into following applications such as traumatic brain injury, stroke, Alzheimer’s disease and others. Urology is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.

By Route of Administration, it is segmented into oral, intravenous and others.

By End User, it is segmented into hospitals, diagnostic centers, research institutes and others.

The global radiopharmaceutical market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa. Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. Currently, these two regions collectively account for the largest share of the market and the trend is likely to continue over the next couple of years. Higher healthcare spending and existence a robust healthcare system system in these regions is reflecting favorably on the market. In Asia Pacific, increased focus on improving the quality of healthcare services is auguring well for market players operating in the region. During the review period, the market in the region is expected to capture a strong CAGR.

Enquire for Discount at:

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Market Research Future

+1 646 845 9312


The post Global Briefing 2018: Radiopharmaceutical Market Therapeutic Survey Analysis Report by Type, Applications and Major Key Findings appeared first on Herald Keeper.